Pfizer
The latest news about Pfizer: headlines, AI summaries and the full story from every source.
- Pfizer Shares Rise for Seven Consecutive Sessions
- Pfizer Acquires Weight-Loss Biotech to Strengthen Pipeline in Growing Market
- Pfizer Faces Setbacks with Clinical Trial Failure and CFO Departure
- Pfizer Faces Setbacks with Clinical Trial Failure and CFO Departure
- Pfizer Announces CFO Dave Denton Will Step Down in August
- Pfizer CFO Dave Denton Steps Down in August 2026
- Pfizer CFO Dave Denton to Step Down in August
- Moderna Surges 94% in 2026 Amid Leadership Restructuring and Upcoming Product Launches
- Pfizer Expands Cancer Pipeline Through Strategic Partnership With Innovent Biologics
- Wolfe Research Raises Price Target for Pfizer Amid Ongoing COVID Uncertainty
- Pfizer Exceeds Earnings and Revenue Estimates, Reaffirms 2026 Outlook
- Pomerantz Law Firm Investigates Valneva SE for Potential Securities Fraud
- Pfizer Secures Patent Extension for Vyndamax, Delaying Generic Competition
- Goldman Sachs Lowers Price Target for Pfizer Ahead of Earnings Report
- Eliquis Faces Major Revenue Decline Due to Patent Expiry
- CureVac Files Patent Infringement Lawsuit Against Moderna Over mRNA Vaccine Technology
- Pfizer's Dividend Yield Rises to 6.3% Amid Concerns Over Future Prospects
- Pfizer's GLP-1 Drug May Challenge Novo Nordisk and Eli Lilly's Market Dominance
- Pfizer and Astellas Receive FDA Priority Review for Padcev
- Pfizer and Amgen Among 22 Firms Expanding in Hong Kong